Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FZH84
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,572
Award facts
- Contract value 100% obligated
- $7,571.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injector medication. This is a firm fixed-price delivery order with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was issued on November 10, 2025, with an ultimate completion date of November 12, 2025, and performance will occur at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025. The parent IDC carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor supporting the Department of Defense's global military healthcare operations. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to supply a comprehensive range of pharmaceuticals and medical consumables to military healthcare facilities worldwide, and this specific delivery order for Nucala supports that broader mission of providing specialized pharmaceutical products to the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FZH84?
SPE2DB26FZH84 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FZH84 worth?
The government has obligated $7,572 on SPE2DB26FZH84.
Is contract SPE2DB26FZH84 an order under another contract?
Yes. SPE2DB26FZH84 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB26FZH84 competed?
The extent of competition for SPE2DB26FZH84 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award